Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Impact of zidovudine-based triple combination therapy on an AIDS drug assistance programJ A Mauskopf, J M Tolson, K N Simpson, et al.
Journal of Minimally Invasive Gynecology|November 11, 2008
Rate, type, and cost of invasive interventions for uterine myomas in Germany, France, and EnglandHerve Fernandez, Martin Farrugia, Siân E Jones, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 24, 2012
Updating and confirming an industry-sponsored pharmacoeconomic model: comparing two antipsychotics in the treatment of schizophreniaChristopher N Graham, Josephine A Mauskopf, Anthony H Lawson, et al.
Pharmacoeconomics|June 8, 2014
Cost effectiveness of darunavir/ritonavir combination antiretroviral therapy for treatment-naive adults with HIV-1 infection in CanadaAnita J Brogan, Erik Smets, Josephine A Mauskopf, et al.
The Journal of Clinical Psychiatry|December 1, 1996
Functional status in depressed patients: the relationship to disease severity and disease resolutionJ A Mauskopf, G P Simeon, M A Miles, et al.
JAMA|July 10, 1996
Economic impact of treatment of HIV-positive pregnant women and their newborns with zidovudine. Implications for HIV screeningJ A Mauskopf, J E Paul, D S Wichman, et al.
CNS Drugs|August 18, 2016
A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to MethylphenidateEvelina A Zimovetz, Stephen M Beard, Paul Hodgkins, et al.
Pharmacoeconomics|August 18, 2000
Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmineA B Hauber, A Gnanasakthy, E H Snyder, et al.
Journal of Clinical Epidemiology|August 16, 2000
Assessing the Saskatchewan database for outcomes research studies of depression and its treatmentS L West, A Richter, C A Melfi, et al.
Journal of Medical Economics|July 28, 2009
Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapyJosephine A Mauskopf, Kristina S Boye, Claude Schmitt, et al.
Pageof 5